UCB Group Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain

August 17, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRUSSELS, BELGIUM--(MARKET WIRE)--Aug 17, 2007 -- Marketing Authorization Application for Vimpat® - the proposed new trade name for lacosamide - to treat Diabetic Neuropathic Pain has been submitted to the European regulatory authority.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Europe